Sökning: WFRF:(Kaneko H) > (2020-2024) > The global Alzheime...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05241naa a2200817 4500 | |
001 | oai:gup.ub.gu.se/310397 | |
003 | SwePub | |
008 | 240528s2021 | |||||||||||000 ||eng| | |
024 | 7 | a https://gup.ub.gu.se/publication/3103972 URI |
024 | 7 | a https://doi.org/10.1002/dad2.122422 DOI |
040 | a (SwePub)gu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Pannee, Josef,d 1979u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry4 aut0 (Swepub:gu)xpajos |
245 | 1 0 | a The global Alzheimer's Association round robin study on plasma amyloid beta methods |
264 | c 2021-10-14 | |
264 | 1 | b Wiley,c 2021 |
520 | a Introduction Blood-based assays to measure brain amyloid beta (A beta) deposition are an attractive alternative to the cerebrospinal fluid (CSF)-based assays currently used in clinical settings. In this study, we examined different blood-based assays to measure A beta and how they compare among centers and assays. Methods Aliquots from 81 plasma samples were distributed to 10 participating centers. Seven immunological assays and four mass-spectrometric methods were used to measure plasma A beta concentrations. Results Correlations were weak for A beta 42 while A beta 40 correlations were stronger. The ratio A beta 42/A beta 40 did not improve the correlations and showed weak correlations. Discussion The poor correlations for A beta 42 in plasma might have several potential explanations, such as the high levels of plasma proteins (compared to CSF), sensitivity to pre-analytical sample handling and specificity, and cross-reactivity of different antibodies. Different methods might also measure different pools of plasma A beta 42. We, however, hypothesize that greater correlations might be seen in future studies because many of the methods have been refined during completion of this study. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Neurovetenskaper0 (SwePub)301052 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Neurosciences0 (SwePub)301052 hsv//eng |
653 | a Alzheimer's disease | |
653 | a amyloid beta | |
653 | a biomarkers | |
653 | a method comparison | |
653 | a plasma | |
653 | a biomarkers | |
653 | a disease | |
653 | a csf | |
653 | a Neurosciences & Neurology | |
700 | 1 | a Shaw, L. M.4 aut |
700 | 1 | a Korecka, M.4 aut |
700 | 1 | a Waligorska, T.4 aut |
700 | 1 | a Teunissen, C. E.4 aut |
700 | 1 | a Stoops, E.4 aut |
700 | 1 | a Vanderstichele, H. M. J.4 aut |
700 | 1 | a Mauroo, K.4 aut |
700 | 1 | a Verberk, I. M. W.4 aut |
700 | 1 | a Keshavan, A.4 aut |
700 | 1 | a Pesini, P.4 aut |
700 | 1 | a Sarasa, L.4 aut |
700 | 1 | a Pascual-Lucas, M.4 aut |
700 | 1 | a Fandos, N.4 aut |
700 | 1 | a Allue, J. A.4 aut |
700 | 1 | a Portelius, Erik,d 1977u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry4 aut0 (Swepub:gu)xporer |
700 | 1 | a Andreasson, Ulf,d 1968u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry4 aut0 (Swepub:gu)xaulfz |
700 | 1 | a Yoda, R.4 aut |
700 | 1 | a Nakamura, A.4 aut |
700 | 1 | a Kaneko, N.4 aut |
700 | 1 | a Yang, S. Y.4 aut |
700 | 1 | a Liu, H. C.4 aut |
700 | 1 | a Palme, S.4 aut |
700 | 1 | a Bittner, T.4 aut |
700 | 1 | a Mawuenyega, K. G.4 aut |
700 | 1 | a Ovod, V.4 aut |
700 | 1 | a Bollinger, J.4 aut |
700 | 1 | a Bateman, R. J.4 aut |
700 | 1 | a Li, Y.4 aut |
700 | 1 | a Dage, J. L.4 aut |
700 | 1 | a Stomrud, E.4 aut |
700 | 1 | a Hansson, O.4 aut |
700 | 1 | a Schott, J. M.4 aut |
700 | 1 | a Blennow, Kaj,d 1958u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry4 aut0 (Swepub:gu)xbleka |
700 | 1 | a Zetterberg, Henrik,d 1973u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry4 aut0 (Swepub:gu)xzethe |
710 | 2 | a Göteborgs universitetb Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi4 org |
773 | 0 | t Alzheimer's & Dementiad : Wileyg 13:1q 13:1x 1552-5260x 1552-5279 |
773 | 0 | t Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoringd : Wileyg 13:1q 13:1x 2352-8729x 2352-8729 |
856 | 4 | u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/dad2.12242 |
856 | 4 8 | u https://gup.ub.gu.se/publication/310397 |
856 | 4 8 | u https://doi.org/10.1002/dad2.12242 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.